🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nazarius S. Lamango

Florida Agricultural and Mechanical University

ORCID: 0000-0002-4906-8933
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A Mechanistic Investigation on the Anticancer Properties of SYA013, a Homopiperazine Analogue of Haloperidol with Activity against Triple Negative Breast Cancer Cells”.

A Mechanistic Investigation on the Anticancer Properties of SYA013, a Homopiperazine Analogue of Haloperidol with Activity against Triple Negative Breast Cancer Cells

ACS Omega(2020)10.1021/acsomega.0c03495
N/A
0DataRank · unranked
13 citations

Felix Amissah, Chandrashekhar Voshavar, Augustine T. Nkembo, Elizabeth Ntantie, Nazarius S. Lamango +2 more

Polyisoprenylated Cysteinyl Amide Inhibitors: A Novel Approach to Controlling Cancers with Hyperactive Growth Signaling

Current Medicinal Chemistry(2020)10.2174/0929867327666201111140825
N/A
0DataRank · unranked
4 citations

Augustine T. Nkembo, Elizabeth Ntantie, Nada Tawfeeq, Nazarius S. Lamango

Synthetic Optimization and MAPK Pathway Activation Anticancer Mechanism of Polyisoprenylated Cysteinyl Amide Inhibitors

Cancers(2021)10.3390/cancers13225757
N/A
0DataRank · unranked
6 citations

Yonghao Jin, Nazarius S. Lamango, Nada Tawfeeq

An Evaluation of the Anticancer Properties of SYA014, a Homopiperazine-Oxime Analog of Haloperidol in Triple Negative Breast Cancer Cells

Cancers(2022)10.3390/cancers14246047
N/A
0DataRank · unranked
12 citations

Chandrashekhar Voshavar, Felix Amissah, Barbara A. Bricker, Nazarius S. Lamango, Seth Y. Ablordeppey +1 more

Lack of racial and ethnic diversity in lung cancer cell lines contributes to lung cancer health disparities

Frontiers in Oncology(2023)10.3389/fonc.2023.1187585
N/A
0DataRank · unranked
6 citations

Eugene Manley, Aaron Neely, Jonathan Castillo, Michele Ramos Correa, Diego A. Velarde +10 more

Florida-California Cancer Research, Education and Engagement (CaRE 2 ) Health Equity Center: Structure, Innovations, and Initial Outcomes

Cancer Control(2023)10.1177/10732748231197878
N/A
0DataRank · unranked
5 citations

Folakemi T. Odedina, John D. Carpten, Kinfe K. Redda, Mariana C. Stern, Janice L. Krieger +51 more

Design and realization of lung organoid cultures for COVID-19 applications

Bio-Design and Manufacturing(2023)10.1007/s42242-023-00255-1
N/A
0DataRank · unranked
5 citations

Tryanni R. Chiaravalloti, Nadine L. Belony, Diana I. Romero, Wenxuan Chai, Christopher C. Leon +5 more

Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines

Oncotarget(2023)10.18632/oncotarget.28390
N/A
0DataRank · unranked
3 citations

Jassy Mary S. Lazarte, Yonghao Jin, Matthew D. Gregory, Nazarius S. Lamango, Nada Tawfeeq

Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis

PLoS ONE(2024)10.1371/journal.pone.0312563
N/A
0DataRank · unranked
6 citations

Kweku Ofosu-Asante, Jassy Mary S. Lazarte, Pablo E. Puente, Nada Tawfeeq, Nadine L. Belony +4 more

PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast cancer cells while disrupting actin filaments and focal adhesion

Oncotarget(2025)10.18632/oncotarget.28759
N/A
0DataRank · unranked
2 citations

Kweku Ofosu-Asante, Syreeta L. Tilghman, Nazarius S. Lamango, Jassy Mary S. Lazarte